SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-041202
Filing Date
2021-08-05
Accepted
2021-08-05 08:08:17
Documents
14
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atrs-8k_20210805.htm   iXBRL 8-K 43105
2 EX-99.1 atrs-ex991_19.htm EX-99.1 452376
3 GRAPHIC gzvmw0bm1tz5000001.jpg GRAPHIC 44018
  Complete submission text file 0001564590-21-041202.txt   705597

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atrs-20210805.xsd EX-101.SCH 5705
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20210805_lab.xml EX-101.LAB 19335
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20210805_pre.xml EX-101.PRE 11501
7 EXTRACTED XBRL INSTANCE DOCUMENT atrs-8k_20210805_htm.xml XML 3543
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 211146426
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences